Sercan Karabulut | Psychiatry | Best Academic Researcher Award

Published on by Cognitive Scientist Awards

Assoc. Prof. Dr. Sercan Karabulut | Psychiatry | Best Academic Researcher Award

Akdeniz University School of Medicine | Turkey

Dr. Sercan Karabulut is a distinguished psychiatrist and academic with a strong educational background from İstanbul Medicine Faculty and earlier training at leading Turkish schools. He completed his residency in psychiatry at İstanbul Medicine Faculty and is fluent in English and German, which has supported his international academic presence. His professional career includes service at prominent state hospitals in Antalya and Van, with his current appointment at Akdeniz University School of Medicine. His research interests span schizophrenia, bipolar disorder, substance use disorders, neuroinflammation, neurodegeneration, personality traits, psychopharmacology, and the cognitive and clinical aspects of addiction. He has published extensively in national and international journals, addressing key issues such as clozapine use in schizophrenia, cognitive impairments in methamphetamine users, psychiatric outcomes of encephalitis, and the interplay between trauma, empathy, and substance use. His research skills include clinical psychiatry, psychometric evaluation, statistical analysis, study design, and long-term patient follow-up. In addition, he has authored book chapters on addiction and psychiatric care and has actively contributed to scientific congresses through oral presentations, panels, and case reports. Recognized for his academic productivity and dedication, he has received honors in scientific meetings and has gained respect as both a clinician and researcher. Overall, Dr. Karabulut’s career demonstrates a sustained commitment to advancing psychiatry through clinical practice, research, and education, making him a valuable contributor to the understanding and treatment of complex psychiatric and addiction-related disorders.

Profile: ORCID

Featured Publications

Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

Published on by Cognitive Scientist Awards

Dr. Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

The Rockefeller University | United States

Dr. Sarah F. Leibowitz is a Research Associate Professor at The Rockefeller University in the Laboratory of Behavioral Neurobiology. With a career dedicated to uncovering the neural basis of addiction, she focuses on how the brain regulates consumption of substances like alcohol and nicotine, as well as high-fat and high-sugar foods. Her pioneering work explores the transition from casual intake to substance dependence, linking specific brain mechanisms to addictive behaviors. Dr. Leibowitz’s research also highlights how emotional traits—such as impulsivity and anxiety—influence substance use. In recent years, she has expanded her work to investigate how maternal diet and drug exposure during pregnancy affect the brain development and behavior of offspring. Her studies reveal persistent neural and behavioral changes that may increase vulnerability to addiction later in life. Through her research, she aims to identify early indicators of addiction risk and explore preventive strategies for substance abuse disorders.

Profile

ORCID

Education

Dr. Sarah F. Leibowitz earned her Ph.D. in behavioral neurobiology, establishing her foundation in neuroscience and psychobiology. Although specific details of her academic institutions are not publicly disclosed, her academic trajectory clearly reflects rigorous training in neurobiology, endocrinology, and developmental neuroscience. Her education emphasized the interplay between brain structure, behavior, and environmental stimuli—especially as related to addiction and nutrition. Over the course of her doctoral and postdoctoral work, she developed specialized expertise in rodent models, neurochemical techniques, and behavioral neuroscience. Her educational background has equipped her to contribute significantly to the understanding of the neural mechanisms underlying addiction, impulsivity, and maternal influences on brain development. Dr. Leibowitz’s academic formation has not only shaped her robust research career but also positioned her as a mentor and thought leader in the intersection of behavioral neuroscience, addiction research, and developmental psychobiology.

 Experience

Dr. Sarah Leibowitz brings decades of experience in behavioral neuroscience, serving as a Research Associate Professor at The Rockefeller University. In this role, she leads research exploring how neurochemical circuits in the brain influence the consumption of addictive substances and palatable foods. Her experience spans experimental neurobiology, developmental studies, and translational addiction research, using advanced rodent models to simulate human behavioral patterns. She has worked extensively on characterizing the neural pathways that control emotional traits such as impulsivity and anxiety, which predispose individuals to addiction. In addition, Dr. Leibowitz has pioneered investigations into prenatal programming—studying how maternal substance use affects offspring neurodevelopment and behavior. Her career has been marked by interdisciplinary collaborations, significant grant support, and mentoring emerging scientists. Dr. Leibowitz’s extensive lab-based research experience has positioned her at the forefront of studies on addiction vulnerability, making meaningful contributions to both basic neuroscience and potential clinical applications.

Awards and Honors

While specific awards and honors for Dr. Sarah F. Leibowitz are not publicly detailed, her long-standing appointment at The Rockefeller University—a prestigious research institution—attests to her outstanding contributions in behavioral neurobiology. Recognition in the scientific community is reflected through her published research, influential collaborations, and leadership in addiction-related neuroscience. She is frequently cited in peer-reviewed journals, indicating strong academic impact and recognition from fellow researchers. Her studies addressing prenatal influences on addiction vulnerability have garnered widespread attention in developmental neuroscience and public health sectors. In addition to academic merit, Dr. Leibowitz’s role as a mentor and educator suggests acknowledgment of her commitment to training the next generation of scientists. The significance and longevity of her research position imply that she has received competitive research funding and peer-reviewed grants, further recognizing the value of her work in advancing understanding of substance use disorders.

Research Focus

Dr. Leibowitz’s research focuses on the neurobiological mechanisms underlying addiction, particularly the transition from use to dependence on substances like alcohol, nicotine, and palatable foods. Her laboratory investigates how neurochemical pathways in various brain regions drive compulsive consumption and are influenced by traits such as novelty seeking, impulsivity, and anxiety. A major area of her research explores the developmental origins of addiction: how maternal consumption of drugs or high-fat/high-sugar diets during pregnancy alters brain development and long-term behavior in offspring. These studies reveal that such prenatal exposures can “reprogram” the brain, increasing susceptibility to substance use disorders in adolescence and adulthood. Through rodent models, Dr. Leibowitz aims to identify biomarkers and early-life predictors of addiction risk, as well as investigate potential interventions for prevention. Her multidisciplinary approach integrates behavioral neuroscience, endocrinology, and developmental biology, contributing valuable insights into addiction’s origins, progression, and possible prevention strategies.

Publications

Title: Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment
Year: 2024
Citations: 2

Title: Utility of the Zebrafish Model for Studying Neuronal and Behavioral Disturbances Induced by Embryonic Exposure to Alcohol, Nicotine, and Cannabis
Year: 2023
Citations: 8

Title: Role of Chemokine Cxcl12a in Mediating the Stimulatory Effects of Ethanol on Embryonic Development of Subpopulations of Hypocretin/Orexin Neurons and Their Projections
Year: 2023
Citations: 10

Title: Embryonic ethanol exposure induces ectopic Hcrt and MCH neurons outside hypothalamus in rats and zebrafish: Role in ethanol‐induced behavioural disturbances
Year: 2022
Citations: 18

Conclusion

Dr. Sarah F. Leibowitz’s work stands at the intersection of neuroscience, behavior, and developmental biology, providing groundbreaking insights into addiction, prenatal brain development, and preventive strategies for substance use disorders, making her a leading figure in behavioral neurobiology and addiction research.

 

Caroline Cecil Kaufman | Clinical Psychology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Caroline Cecil Kaufman | Clinical Psychology | Best Researcher Award

Dr. Caroline C. Kaufman is an Assistant Psychologist at McLean Hospital and Instructor in Psychiatry at Harvard Medical School. She earned her Ph.D. in Clinical Psychology from the University of Memphis, with a specialization in the psychology of religion and spirituality. Her work lies at the intersection of spirituality, trauma, and mental health, particularly among underserved and marginalized populations. Dr. Kaufman has developed spiritually integrated psychotherapeutic interventions and conducted groundbreaking research on antisemitism, PTSD, and alcohol misuse. She has trained at leading institutions, including Yale School of Medicine, and currently leads multiple funded projects aimed at adapting clinical care to spiritual and religious diversity. Dr. Kaufman is widely recognized for her academic contributions and advocacy for inclusive behavioral health. Her professional mission centers on empowering vulnerable communities through evidence-based, spiritually inclusive mental health research and care. She is also a frequent speaker and active contributor to national and international psychology organizations.

Profile

🎓 Education

Dr. Kaufman’s clinical and academic experience spans leading institutions in psychology and psychiatry. She currently serves as Assistant Psychologist at McLean Hospital and Instructor at Harvard Medical School. From 2021 to 2023, she was a Postdoctoral Fellow in the Spirituality and Mental Health Program at McLean. Her internship was at Yale-New Haven Hospital, where she worked in child and adolescent intensive outpatient care and the Yale Gender Program. She has held clinical roles across diverse settings, including Le Bonheur Children’s Hospital, Daybreak Treatment Center, and Head Start programs. She also held supervisory roles, including at Yale and the University of Memphis. Dr. Kaufman has been actively engaged in research, professional service, and teaching throughout her career. Her expertise lies in integrating spirituality and trauma-focused therapies, and she serves as Principal Investigator on several funded research projects. She also advises diversity and inclusion initiatives across clinical psychology organizations.

🧪 Experience

Dr. Kaufman has received numerous accolades for her academic and clinical contributions. In 2024, she was awarded the Eleanor and Miles Shore Fellowship by McLean Hospital and Harvard Medical School. She is a 2022 Livingston Fellow at Harvard Medical School and was selected for the prestigious Yale Program for Medicine, Spirituality, & Religion Fellowship in 2020. That same year, she received the Jewish Community Hero Award. Other honors include the International Research Network’s Early Career Researcher Award (2022), the Graduate Student Talk Award from the Tennessee Psychological Association (2018), and the Sigma Xi Undergraduate Research Award from Williams College (2015). Dr. Kaufman has been consistently recognized for her innovative research in spirituality and mental health, her leadership in DEI initiatives, and her commitment to advancing culturally sensitive clinical care. She also received multiple travel and presentation awards from the APA and other scholarly organizations throughout her academic training.

🏅 Awards and Honors

Dr. Kaufman has received numerous accolades for her academic and clinical contributions. In 2024, she was awarded the Eleanor and Miles Shore Fellowship by McLean Hospital and Harvard Medical School. She is a 2022 Livingston Fellow at Harvard Medical School and was selected for the prestigious Yale Program for Medicine, Spirituality, & Religion Fellowship in 2020. That same year, she received the Jewish Community Hero Award. Other honors include the International Research Network’s Early Career Researcher Award (2022), the Graduate Student Talk Award from the Tennessee Psychological Association (2018), and the Sigma Xi Undergraduate Research Award from Williams College (2015). Dr. Kaufman has been consistently recognized for her innovative research in spirituality and mental health, her leadership in DEI initiatives, and her commitment to advancing culturally sensitive clinical care. She also received multiple travel and presentation awards from the APA and other scholarly organizations throughout her academic training.

🔬 Research Focus

Dr. Kaufman’s research focuses on the integration of spirituality, religiosity, and psychological science, particularly in the treatment of trauma, PTSD, and alcohol misuse. Her scholarship explores how spiritual identity and belief systems influence mental health outcomes, with a strong emphasis on marginalized and high-risk populations such as first responders and Jewish communities facing antisemitism. She leads several research projects, funded by organizations such as the John Templeton Foundation and Harvard Medical School, examining spiritually integrated psychotherapy, resilience among trauma survivors, and inclusion of religious diversity in behavioral health. She also investigates antisemitic prejudice and its psychological effects. Through both qualitative and quantitative methodologies, her work advances clinical science by developing culturally and spiritually sensitive interventions. Dr. Kaufman’s interdisciplinary research informs clinical practices and policy frameworks to promote inclusive, evidence-based care. She also collaborates across academic and community settings to ensure her research has practical, population-level impact.

✅ Conclusion

Publications

  • Mental Health Clinical Pastoral Education—A Specialized CPE Program

    Religions
    2025-07 | Journal article | Author
    DOI: 10.3390/rel16070886
    CONTRIBUTORS: Angelika A. Zollfrank; Caroline Cecil Kaufman; David H. Rosmarin

  • The scale matters: assessing body size with figure rating scales in a diverse sample of young adults

    Eating and Weight Disorders
    2022 | Journal article
    DOI: 10.1007/s40519-021-01166-9

  • Integrating Spirituality in Group Psychotherapy with First Responders: Addressing Trauma and Substance Misuse

    Religions
    2022-11 | Journal article | Author
    DOI: 10.3390/rel13121132
    CONTRIBUTORS: Caroline Cecil Kaufman; David Hillel Rosmarin; Hilary Connery

  • Parenting in matched pairs of women of color experiencing intimate partner violence and living with and without HIV

    Journal of Traumatic Stress
    2021 | Journal article
    DOI: 10.1002/jts.22737
    EID: 2-s2.0-85116930252
    Part of ISSN: 15736598 08949867
    CONTRIBUTORS: Thurston, I.B.; Howell, K.H.; Kaufman, C.C.; Mandell, J.E.; Decker, K.M.